Healthcare Industry News: dysphagia
News Release - February 5, 2010
Study Suggests Slide-On(R) EndoSheath(R) System Provides Several Advantages over Traditional Germicidal ImmersionStudy Presented at the Combined Sections Meetings of the Triological Society, the most prestigious society in Otolaryngology, received the John J. Conley Resident Research Award (Eastern Section)
MINNEAPOLIS--(HSMN NewsFeed)--Results of a clinical study presented Thursday, Feb. 4 at the annual Triological Society meetings in Orlando, Fla., suggest a sterile barrier sheath system has distinct advantages over germicidal immersion processes used to prevent contamination of fiberoptic nasopharyngolaryngoscopes (flexible ENT scopes). Flexible ENT scopes are used by otolaryngologists to examine the nose and throat area for various disorders such as dysphagia, reflux disease, snoring, and chronic sinusitis.
Study authors Alphi Elackattu, MD; Mary Zoccoli, MD; Jeffrey H. Spiegel, MD, FACS; and Kenneth M. Grundfast, MD, FACS, all from Boston University School of Medicine, note in their conclusion that through the use of sterile disposable sheaths, physicians will be able to prevent cross-contamination. Using the individually packaged disposable sterile sheaths has been cleared by the U.S. Food and Drug Administration as an acceptable alternative to high level disinfection following endoscope use.
The Medtronic Slide-On™ EndoSheath® System is a sterile, disposable cover for flexible endoscopes that provides a latex-free barrier between the scope and the patient. The system is designed to reduce patient contact with organic debris and staff exposure to hazardous chemicals. The study authors noted that the system is an alternative to time-intensive chemical reprocessing, allows for quick scope turnaround and helps physicians maximize time treating patients.
“The EndoSheath System is designed to allow physicians to cover the insertion tube of the flexible ENT scope with a sterile microbial barrier when performing endoscopy procedures in the clinic and office environments,” said Janis Saunier, marketing director for the ENT division at Medtronic. “We believe the use of a sterile sheath on a nasopharyngoscope, combined with enzymatic detergent cleaning and disinfection with 70 percent alcohol, can provide a reliably decontaminated, patient-ready instrument, providing an acceptable alternative to high-level disinfection of endoscopes.”
About the ENT Business at Medtronic
Located in Jacksonville, Florida, the Ear Nose and Throat (ENT) division at Medtronic develops and manufactures products designed to treat ENT diseases. As the market leader in ENT, Medtronic is changing the way ENT surgery is performed with innovative, minimally invasive products and techniques that benefit both patients and surgeons. Main products include powered tissue-removal systems and other microendoscopy instruments, nerve monitoring systems, sleep-disordered breathing therapies, image-guided surgery systems, disposable fluid control products, and a Ménière's disease therapy device. Learn more about the ENT business on the web at www.MedtronicENT.com.
Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 24, 2009. Actual results may differ materially from anticipated results.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsMedtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.